BRN brainchip holdings ltd

0.00%

20.5¢

Ann: BrainChip Evaluates Redomiciling to US, page-701

First 701 Last

Share
Profile

Follow
hopalongpetrovski

1,174 Posts.

591

17/04/25

16:32

Post #: 78733110
Share
Originally posted by Coit ↑

I was finding this to be a fascinating, vigorous, debate which made me wonder why people are worried about losing their investment in BRN

Our new mate Chat GPT has helped me out. Seems like we aren’t forced sellers. Was that the concern. I have ComSec International so it would be pretty straight forward I expect. anything I am missing here?

If a company like BrainChip, which of is currently listed on the ASX, chooses to delist from the ASX and list on a U.S. exchange (like the NASDAQ or NYSE), here’s what typically happens to the shares held by Australian investors:

1.
Notification and Transition Period

The company would issue an official announcement outlining the delisting plans, reasoning, and timeline.

Investors would be given advance notice to decide how they want to manage their holdings.

2.
Options for Australian Shareholders

Australian shareholders generally have a few options:

a.
Convert to U.S.-listed Shares (ADRs or Direct Holding)

Investors can choose to convert their ASX-listed shares into U.S.-listed shares, often via a share registry or broker-assisted process.

This could involve:

Transferring holdings to a broker that can trade U.S. stocks.

Potentially receiving American Depositary Receipts (ADRs), if offered.

Fulfilling any regulatory/identity requirements (like W-8BEN tax forms).

b.
Sell Shares Before Delisting

Investors may choose to sell their shares on the ASX before the delisting date to avoid complexity or foreign exchange/tax exposure.

c.
Hold Shares via International Broker

If investors don’t sell or convert, some brokers (like CommSec International, Interactive Brokers, etc.) may allow them to continue holding and trading the U.S.-listed shares.

3.
Implications to Consider

FX risk: U.S. shares are traded in USD.

Tax implications: May involve U.S. tax reporting (withholding, W-8BEN, etc.).

Liquidity: Depends on how popular the stock becomes on the U.S. exchange.

Broker capability: Not all Australian brokers support U.S. trading—investors might need to switch.

Summary

If BrainChip delisted from the ASX and relisted in the U.S., Australian investors would either:

Convert to U.S.-listed shares (possibly via a custodian or broker),

Sell their ASX shares before the delisting,

Or move to an international broker to continue holding/trading.

Expand

What about the people who are holding in their retail superannuation funds though?
Many of them will be forced sellers unfortunately and at current prices, likely to suffer losses.
Not all funds will accomodate the move to a USA exchange.
BRN Price at posting: 25.5¢ Sentiment: Buy Disclosure: Held
8 Upvote

1 Great analysis

Reply

Top Stories

Friday’s HotCopper trends: Dreadnoughts's drill delight, Galan's beaut raise | June 19

Thursday's HotCopper trends: Second Amplia response, Race combo dosing | June 19

Week 25 Wrap: Fed & BoE pause rates ahead of RBA; Santos-ADNOC, Oz tax reforms

NVO

Novo flags antimony and gold in the Pilbara – but does it need to step back?

ASX Market Open: Stocks slide as Trump tosses up attacking Iran directly | June 20

HotCopper Highlights for Week 25: 4DS Memory, Meeka & Sprott-citement

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

AL3

AML3D opens new facility in Ohio as US Defence strategy bears fruit

PV1

Hydrogen tanker stock Provaris inks MOU with "K" LINE to provide advice

PIQ

Proteomics notches up as company launches PromarkerD into the US

First 701 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 20.5¢		Change 0.000(0.00%)		Mkt cap ! $415.2M

Open	High	Low	Value	Volume
20.5¢	20.5¢	20.0¢	$1.772M	8.682M

Buyers (Bids)

No.	Vol.	Price($)
90	4124462	20.0¢

Sellers (Offers)

Price($)	Vol.	No.
20.5¢	1073114	20

View Market Depth

No.	Vol.	Price($)
62	959691	0.200
20	970993	0.195
35	609339	0.190
21	499787	0.185
31	519036	0.180

Price($)	Vol.	No.
0.205	705763	15
0.210	748097	18
0.215	829785	21
0.220	855846	26
0.225	1074415	19

Last trade - 16.10pm 20/06/2025 (20 minute delay)

BRN (ASX) Chart

Ann: BrainChip Evaluates Redomiciling to US, page-701

Friday’s HotCopper trends: Dreadnoughts's drill delight, Galan's beaut raise | June 19

Thursday's HotCopper trends: Second Amplia response, Race combo dosing | June 19

Week 25 Wrap: Fed & BoE pause rates ahead of RBA; Santos-ADNOC, Oz tax reforms

Novo flags antimony and gold in the Pilbara – but does it need to step back?

ASX Market Open: Stocks slide as Trump tosses up attacking Iran directly | June 20

HotCopper Highlights for Week 25: 4DS Memory, Meeka & Sprott-citement

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

AML3D opens new facility in Ohio as US Defence strategy bears fruit

Hydrogen tanker stock Provaris inks MOU with "K" LINE to provide advice

Proteomics notches up as company launches PromarkerD into the US

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: BrainChip Evaluates Redomiciling to US, page-701

Top Stories

Friday’s HotCopper trends: Dreadnoughts's drill delight, Galan's beaut raise | June 19

Thursday's HotCopper trends: Second Amplia response, Race combo dosing | June 19

Week 25 Wrap: Fed & BoE pause rates ahead of RBA; Santos-ADNOC, Oz tax reforms

Novo flags antimony and gold in the Pilbara – but does it need to step back?

ASX Market Open: Stocks slide as Trump tosses up attacking Iran directly | June 20

HotCopper Highlights for Week 25: 4DS Memory, Meeka & Sprott-citement

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

AML3D opens new facility in Ohio as US Defence strategy bears fruit

Hydrogen tanker stock Provaris inks MOU with "K" LINE to provide advice

Proteomics notches up as company launches PromarkerD into the US

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News